2024/10/18 17:44:59 | |
---|---|
Price | |
100.70 EUR | |
Difference | -0.32% (-0.32) |
ISIN | FR0000120578 |
Symbol | SAN |
Exchange | Euronext Milan MTF Global Equity Market |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 126,386 EUR |
Benchmark | CAC 40 INDEX |
Bid (Bid size) | 100.02 EUR (50) |
Ask (Ask size) | 103.00 EUR (100) |
Open | 100.46 EUR |
High | 100.54 EUR |
Low | 100.36 EUR |
Close (prev. day) | 101.02 EUR |
VWAP | 100.472279 EUR |
Volume (pcs) | 544 |
Trading volume | 54,657.00 |
Number of trades | 5 |
Last size | - |
Related Futures | 49 |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 17:44:59 | |
---|---|
Price | |
100.70 EUR | |
Difference | -0.32% (-0.32) |
ISIN | FR0000120578 |
Symbol | SAN |
Exchange | Euronext Milan MTF Global Equity Market |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 126,386 EUR |
Benchmark | CAC 40 INDEX |
Bid (Bid size) | 100.02 EUR (50) |
Ask (Ask size) | 103.00 EUR (100) |
Open | 100.46 EUR |
High | 100.54 EUR |
Low | 100.36 EUR |
Close (prev. day) | 101.02 EUR |
VWAP | 100.472279 EUR |
Volume (pcs) | 544 |
Trading volume | 54,657.00 |
Number of trades | 5 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | +18.19% | -0.69% | +21.77% |
Perf (abs.) | +15.50 | -0.70 | +18.00 |
Beta | 0.48 | 0.61 | 0.43 |
Volatility | 26.52 | 28.51 | 24.97 |
Ø price 5 days | Ø volume 5 days (pcs.) | 100.94 EUR (632) |
Ø price 30 days | Ø volume 30 days (pcs.) | 102.26 EUR (463) |
Ø price 100 days | Ø volume 100 days (pcs.) | 96.58 EUR (878) |
Ø price 250 days | Ø volume 250 days (pcs.) | 91.97 EUR (933) |
YTD High | date | 107.96 EUR (2024/08/19) |
YTD Low | date | 84.97 EUR (2024/02/14) |
52 Weeks High | date | 107.96 EUR (2024/08/19) |
52 Weeks Low | date | 80.75 EUR (2023/10/27) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/10/18 | 17:35 | 100.58 EUR | 0.18 | 66 |
Vienna Stock Exchange | 2024/10/18 | 15:30 | 100.64 EUR | 0.00 | 4 |
Tradegate | 2024/10/18 | 22:26 | 100.72 EUR | 0.50 | 54 |
Stuttgart | 2024/10/18 | 21:55 | 100.70 EUR | 0.08 | 71 |
Munich | 2024/10/18 | 13:19 | 100.50 EUR | 0.00 | 4 |
London Stock Exchange European Trade Reporting | 2024/10/18 | 17:30 | 100.585 EUR | 0.02 | 5 |
Hanover | 2024/10/18 | 08:09 | 101.34 EUR | 0.00 | 1 |
Hamburg | 2024/10/18 | 17:25 | 100.68 EUR | 0.11 | 4 |
Frankfurt | 2024/10/18 | 19:29 | 100.70 EUR | 0.09 | 10 |
FINRA other OTC Issues | 2024/10/17 | 19:07 | 104.47 USD | 0.13 | 8 |
Euronext Paris | 2024/10/18 | 17:39 | 100.82 EUR | 119.08 | 9,497 |
Euronext Milan MTF Trading After Hours | 2024/10/14 | 18:00 | 104.62 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/10/18 | 17:44 | 100.70 EUR | 0.05 | 5 |
Duesseldorf | 2024/10/18 | 19:30 | 100.42 EUR | 0.00 | 7 |
Berlin | 2024/10/18 | 08:08 | 100.86 EUR | 0.00 | 2 |
SANOFI |
- - |
46, avenue de la Grande Armée - 75017 Paris |
Telefon: +33-1-53-77-40-00 |
Fax: +33-1-53-77-44-03 |
E-mail: - |
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France. |
Paul Hudson | Chairman of Managing Board |
Brendan O'Callaghan | Member of Executive Committee |
Brian Foard | Member of Executive Committee |
Emmanuel Frenehard | Member of Executive Committee |
Francois Roger | Member of Executive Committee |
Houman Ashrafian | Member of Executive Committee |
Julie Van Ongevalle | Member of Executive Committee |
Madeleine Roach | Member of Executive Committee |
Natalie Bickford | Member of Executive Committee |
Olivier Charmeil | Member of Executive Committee |
Roy Papatheodorou | Member of Executive Committee |
Thomas Triomphe | Member of Executive Committee |
Frédéric Oudéa | Chairman of Supervisory Board |
Antoine Yver | Member of Supervisory Board |
Emile Voest | Member of Supervisory Board |
John Sundy | Member of Supervisory Board |
Wolfgang Laux | Member of Supervisory Board |
Anne-Francoise Nesmes | Member of Supervisory Board |
Barbara Lavernos | Member of Supervisory Board |
Carole Ferrand | Member of Supervisory Board |
Christophe Babule | Member of Supervisory Board |
Clotilde Delbos | Member of Supervisory Board |
Fabienne Lecorvaisier | Member of Supervisory Board |
Gilles Schnepp | Member of Supervisory Board |
Lise Kingo | Member of Supervisory Board |
Patrick Kron | Member of Supervisory Board |
Rachel Duan | Member of Supervisory Board |
Yann Tran | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer